08. Atrial Fibrillation, Atrial Flutter, and Anticoagulation Strategies
Atrial Fibrillation (AF) and Atrial Flutter (A-Flutter) are the most prevalent sustained supraventricular arrhythmias in adults, conferring substantial risks of thromboembolic stroke, heart failure, and mortality.
Figure 8.1: 12-lead ECG of Atrial Fibrillation showing irregular R-R intervals, absent discrete P waves, and fibrillatory baseline activity. Rendered with solid white background.
1. Diagnostic Electrocardiographic Criteria
| Arrhythmia | Atrial Rate & Morphology | Ventricular Rate & Regularity | Diagnostic Hallmarks |
|---|---|---|---|
| Atrial Fibrillation (AF) | Irregular fibrillatory waves ($f$ waves) at $>400-600\text{ bpm}$. | Irregularly irregular R-R intervals. | Absence of coordinated P waves; variable baseline undulation. |
| Typical Atrial Flutter (Counterclockwise) | Regular sawtooth flutter waves ($F$ waves) at $\sim 300\text{ bpm}$ (range $240-350\text{ bpm}$). | Regular with fixed AV conduction (typically $2:1 \to 150\text{ bpm}$, $3:1 \to 100\text{ bpm}$, $4:1 \to 75\text{ bpm}$). | Negative sawtooth $F$ waves in leads II, III, aVF and upright positive $F$ in lead $V_1$. |
| Atypical Atrial Flutter (Clockwise) | Sawtooth flutter waves at $\sim 300\text{ bpm}$. | Regular with fixed or variable AV conduction. | Positive $F$ waves in inferior leads (II, III, aVF) and negative $F$ in $V_1$. |
| Pre-Excited AF (AF + WPW / "FBI" Rhythm) | Atrial fibrillation conducting down accessory pathway. | Fast, Broad, Irregular (FBI) rhythm; ventricular rates often $>250-300\text{ bpm}$. | Emergency: High risk of degenerating into Ventricular Fibrillation; AV nodal blockers strictly contraindicated. |
2. Stroke Risk Stratification: The $\text{CHA}_2\text{DS}_2\text{-VASc}$ Score
$$\text{Score} \ge 2 \text{ in men (or } \ge 3 \text{ in women)} \implies \text{Class I Indication for Oral Anticoagulation}$$- Congestive Heart Failure: 1 pt
- Hypertension: 1 pt
- Age $\ge 75$ years: 2 pts
- Diabetes Mellitus: 1 pt
- Stroke / TIA / Thromboembolism: 2 pts
- Vascular Disease (prior MI, PAD, aortic plaque): 1 pt
- Age 65-74 years: 1 pt
- Sex Category (Female): 1 pt
3. Evidence-Based Management Protocols
- Direct Oral Anticoagulants (DOACs): First-line over Warfarin (Apixaban $5\text{ mg}$ bid, Rivaroxaban $20\text{ mg}$ daily, Dabigatran $150\text{ mg}$ bid, Edoxaban $60\text{ mg}$ daily).
- Rate Control: Beta-blockers (Metoprolol, Bisoprolol), Non-DHP Calcium Channel Blockers (Diltiazem), or Digoxin.
- Rhythm Control: Antiarrhythmics (Flecainide/Propafenone in structurally normal hearts; Amiodarone/Dronedarone in structural heart disease).
- Catheter Ablation: Pulmonary Vein Isolation (PVI) via Cryoballoon, Radiofrequency, or Pulsed Field Ablation (PFA); Cavotricuspid Isthmus (CTI) Ablation for typical atrial flutter ($>95\%$ curative).
- Left Atrial Appendage Occlusion (LAAO): Watchman / Amulet device in patients with contraindications to long-term anticoagulation.